American Century Companies’s BioSpecifics Technologies Corp. BSTC Stock Holding History

American Century Companies’s Portfolio BSTC Stock Details BSTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-41,737	Closed	-$2.49M	–	1372
2019 Q2	$2.49M	Buy	41,737 +1,895	+5%	+$119K	﹤0.01%	992
2019 Q1	$2.48M	Sell	39,842 -125	-0.3%	-$8.27K	﹤0.01%	966
2018 Q4	$2.42M	Buy	39,967 +30,894	+341%	+$1.85M	﹤0.01%	935
2018 Q3	$531K	Sell	9,073 -1,032	-10%	-$52.7K	﹤0.01%	1167
2018 Q2	$453K	Sell	10,105 -1,115	-10%	-$48K	﹤0.01%	1199
2018 Q1	$497K	Sell	11,220 -235	-2%	-$9.87K	﹤0.01%	1165
2017 Q4	$496K	Sell	11,455 -14,152	-55%	-$636K	﹤0.01%	1193
2017 Q3	$1.19M	Sell	25,607 -4,854	-16%	-$232K	﹤0.01%	1116
2017 Q2	$1.51M	Buy	30,461 +302	+1%	+$15.8K	﹤0.01%	1078
2017 Q1	$1.65M	Sell	30,159 -2,644	-8%	-$140K	﹤0.01%	1070
2016 Q4	$1.83M	Sell	32,803 -2,297	-7%	-$110K	﹤0.01%	1053
2016 Q3	$1.6M	Sell	35,100 -21,235	-38%	-$853K	﹤0.01%	1092
2016 Q2	$2.25M	Buy	56,335 +20,979	+59%	+$768K	﹤0.01%	1004
2016 Q1	$1.23M	Buy	35,356 +1,976	+6%	+$72.5K	﹤0.01%	1076
2015 Q4	$1.43M	Buy	33,380 +307	+0.9%	+$15.4K	﹤0.01%	1071
2015 Q3	$1.44M	Buy	33,073 +7,367	+29%	+$398K	﹤0.01%	1061
2015 Q2	$1.33M	Buy	25,706 +131	+0.5%	+$5.59K	﹤0.01%	1102
2015 Q1	$1M	Buy	25,575 +5,797	+29%	+$227K	﹤0.01%	1149
2014 Q4	$764K	Buy	+19,778	New	+$755K	﹤0.01%	1229

Other funds holding BSTC

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

American Century Companies's BSTC Position: Q3 2019 in Review

American Century Companies sold out of BioSpecifics Technologies Corp. (BSTC) in Q3 2019, closing a stake of 41,737 shares — an estimated $2.49M sold.

American Century Companies first reported a position in BSTC in Q4 2014 and held it in 19 quarters. The position peaked at $2.49M in Q2 2019. 114 funds tracked by Wall St. Rank hold BSTC as of Q3 2019.

American Century Companies reported no remaining BioSpecifics Technologies Corp. position as of Q3 2019 after selling out during the quarter.
American Century Companies sold 41,737 BioSpecifics Technologies Corp. shares in Q3 2019, an estimated $2.49M.
American Century Companies first reported a position in BioSpecifics Technologies Corp. in Q4 2014 and held it in 19 quarters.
American Century Companies's BioSpecifics Technologies Corp. position peaked at $2.49M in Q2 2019.
114 funds tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q3 2019.

Based on American Century Companies's 13F filing for Q3 2019, filed 13 Nov 2019.